{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:47Z","timestamp":1787725847035,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"DOI":"10.7759\/cureus.87755","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T05:52:47Z","timestamp":1752299567000},"source":"Crossref","is-referenced-by-count":5,"title":["Adipokine Dysregulation in Obese and Non-Obese Polycystic Ovary Syndrome (PCOS) Patients: Association With Visceral Adiposity Index and Metabolic Risk"],"prefix":"10.7759","author":[{"given":"Minakshi","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhuma","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32351","article-title":"Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis","volume":"14","author":"Bharali MD","year":"2022","unstructured":"Bharali MD, Rajendran R, Goswami J, et al.. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. 2022, 14:e32351. 10.7759\/cureus.32351","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmy022","article-title":"Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Skiba MA","year":"2018","unstructured":"Skiba MA, Islam RM, Bell RJ, Davis SR. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018, 24:694-709. 10.1093\/humupd\/dmy022","journal-title":"Hum Reprod Update"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/life12121974","article-title":"Polycystic ovary syndrome: an updated overview foregrounding impacts of ethnicities and geographic variations","volume":"12","author":"Yasmin A","year":"2022","unstructured":"Yasmin A, Roychoudhury S, Paul Choudhury A, et al.. Polycystic ovary syndrome: an updated overview foregrounding impacts of ethnicities and geographic variations. Life (Basel). 2022, 12:10.3390\/life12121974","journal-title":"Life (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM\u2010Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM\u2010Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-7. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102503","article-title":"The complex roles of adipokines in polycystic ovary syndrome and endometriosis","volume":"10","author":"Sch\u00fcler-Toprak S","year":"2022","unstructured":"Sch\u00fcler-Toprak S, Ortmann O, Buechler C, Treeck O. The complex roles of adipokines in polycystic ovary syndrome and endometriosis. Biomedicines. 2022, 10:10.3390\/biomedicines10102503","journal-title":"Biomedicines"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmab004","article-title":"Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome","volume":"27","author":"de Medeiros SF","year":"2021","unstructured":"de Medeiros SF, Rodgers RJ, Norman RJ. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome. Hum Reprod Update. 2021, 27:771-96. 10.1093\/humupd\/dmab004","journal-title":"Hum Reprod Update"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0078","article-title":"IL-6 and TNF-\u03b1 induced obesity-related inflammatory response through transcriptional regulation of miR-146b","volume":"34","author":"Shi C","year":"2014","unstructured":"Shi C, Zhu L, Chen X, et al.. IL-6 and TNF-\u03b1 induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J Interferon Cytokine Res. 2014, 34:342-8. 10.1089\/jir.2013.0078","journal-title":"J Interferon Cytokine Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.03.012","article-title":"Diagnosis, phenotype, and prevalence of polycystic ovary syndrome","volume":"86 Suppl 1","author":"Carmina E","year":"2006","unstructured":"Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril. 2006, 86 Suppl 1:S7-8. 10.1016\/j.fertnstert.2006.03.012","journal-title":"Fertil Steril"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163652","article-title":"Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study","volume":"15","author":"Jurczewska J","year":"2023","unstructured":"Jurczewska J, Ostrowska J, Che\u0142chowska M, et al.. Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study. Nutrients. 2023, 15:10.3390\/nu15163652","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril F","year":"2023","unstructured":"Bril F, Ezeh U, Amiri M, et al.. Adipose tissue dysfunction in polycystic ovary syndrome. J Clin Endocrinol Metab. 2023, 109:10-24. 10.1210\/clinem\/dgad356","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng Y","year":"2022","unstructured":"Peng Y, Yang H, Song J, et al.. Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022, 13:845165. 10.3389\/fendo.2022.845165","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5455\/2319-2003.ijbcp20140224","article-title":"Leptin in non PCOS and PCOS women: a comparative study","volume":"3","author":"Sunita JR","year":"2017","unstructured":"Sunita JR, Jaiprakash BR, Jain SS, et al.. Leptin in non PCOS and PCOS women: a comparative study. Int J Basic Clin Pharmacol. 2017, 3:186-93. 10.5455\/2319-2003.ijbcp20140224","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.180005","article-title":"Leptin and body mass index in polycystic ovary syndrome","volume":"20","author":"Jalilian N","year":"2016","unstructured":"Jalilian N, Haghnazari L, Rasolinia S. Leptin and body mass index in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016, 20:324-8. 10.4103\/2230-8210.180005","journal-title":"Indian J Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092753","article-title":"The association of serum levels of leptin and ghrelin with the dietary fat content in non-obese women with polycystic ovary syndrome","volume":"12","author":"Polak AM","year":"2020","unstructured":"Polak AM, Krentowska A, \u0141ebkowska A, et al.. The association of serum levels of leptin and ghrelin with the dietary fat content in non-obese women with polycystic ovary syndrome. Nutrients. 2020, 12:10.3390\/nu12092753","journal-title":"Nutrients"},{"key":"ref15","article-title":"Adiponectin: an indicator for metabolic syndrome","volume":"48","author":"YO S","year":"2019","unstructured":"YO S, KH M, ES A, et al.. Adiponectin: an indicator for metabolic syndrome. Iran J Public Health. 2019, 48:1106-15.","journal-title":"Iran J Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108706","article-title":"Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity","volume":"38","author":"de Luis D","year":"2024","unstructured":"de Luis D, Primo D, Izaola O, Gomez JJ. Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity. J Diabetes Complications. 2024, 38:108706. 10.1016\/j.jdiacomp.2024.108706","journal-title":"J Diabetes Complications"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.jhrs_95_23","article-title":"A study of serum adiponectin levels in patients with polycystic ovarian syndrome and its correlation with various cardiometabolic risk markers","volume":"16","author":"Prasad GS","year":"2023","unstructured":"Prasad GS, Saikia UK, Bhuyan AK, Baro A. A study of serum adiponectin levels in patients with polycystic ovarian syndrome and its correlation with various cardiometabolic risk markers. J Hum Reprod Sci. 2023, 16:299-306. 10.4103\/jhrs.jhrs_95_23","journal-title":"J Hum Reprod Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.921067","article-title":"Association between visceral adiposity index and insulin resistance: a cross-sectional study based on US adults","volume":"13","author":"Jiang K","year":"2022","unstructured":"Jiang K, Luan H, Pu X, et al.. Association between visceral adiposity index and insulin resistance: a cross-sectional study based on US adults. Front Endocrinol (Lausanne). 2022, 13:921067. 10.3389\/fendo.2022.921067","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01399","article-title":"Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and meta-analysis","volume":"10","author":"Su KZ","year":"2019","unstructured":"Su KZ, Li YR, Zhang D, et al.. Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and meta-analysis. Front Physiol. 2019, 10:1399. 10.3389\/fphys.2019.01399","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20240796","article-title":"Role of proinflammatory cytokines TNF-\u03b1 (rs1800629) and IL-6 (rs1800795) in the pathogenesis of polycystic ovarian syndrome in North Indian females","volume":"13","author":"Kaur P","year":"2024","unstructured":"Kaur P, Kaur K, Kaur R. Role of proinflammatory cytokines TNF-\u03b1 (rs1800629) and IL-6 (rs1800795) in the pathogenesis of polycystic ovarian syndrome in North Indian females. Int J Reprod Contracept Obstet Gynecol. 2024, 13:963-70. 10.18203\/2320-1770.ijrcog20240796","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20230783","article-title":"A comparative study of insulin levels in lean versus obese polycystic ovarian syndrome patients","volume":"12","author":"Sethi N","year":"2023","unstructured":"Sethi N, Puri S, Malhotra A. A comparative study of insulin levels in lean versus obese polycystic ovarian syndrome patients. Int J Reprod Contracept Obstet Gynecol. 2023, 12:893-7. 10.18203\/2320-1770.ijrcog20230783","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.82672","article-title":"How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models","volume":"15","author":"Lewandowski KC","year":"2019","unstructured":"Lewandowski KC, Skowro\u0144ska-J\u00f3\u017awiak E, \u0141ukasiak K, et al.. How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models. Arch Med Sci. 2019, 15:613-8. 10.5114\/aoms.2019.82672","journal-title":"Arch Med Sci"},{"key":"ref23","article-title":"Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients","volume":"14","author":"Layegh P","year":"2016","unstructured":"Layegh P, Mousavi Z, Farrokh TD, et al.. Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients. Int J Reprod Biomed. 2016, 14:263-70.","journal-title":"Int J Reprod Biomed"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2024.1475132","article-title":"The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence","volume":"6","author":"Bushell A","year":"2024","unstructured":"Bushell A, Crespi BJ. The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence. Front Reprod Health. 2024, 6:1475132. 10.3389\/frph.2024.1475132","journal-title":"Front Reprod Health"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741764","article-title":"Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome","volume":"12","author":"Ding H","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, et al.. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021, 12:741764. 10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal R","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020, 13:261-71. 10.4103\/jhrs.JHRS_95_18","journal-title":"J Hum Reprod Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0527","article-title":"Higher blood pressure in normal weight women with PCOS compared to controls","volume":"10","author":"Mellembakken JR","year":"2021","unstructured":"Mellembakken JR, Mahmoudan A, M\u00f8rkrid L, et al.. Higher blood pressure in normal weight women with PCOS compared to controls. Endocr Connect. 2021, 10:154-63. 10.1530\/EC-20-0527","journal-title":"Endocr Connect"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.15171\/jcvtr.2018.10","article-title":"Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"10","author":"Hallajzadeh J","year":"2018","unstructured":"Hallajzadeh J, Khoramdad M, Karamzad N, et al.. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res. 2018, 10:56-69. 10.15171\/jcvtr.2018.10","journal-title":"J Cardiovasc Thorac Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.30699\/jogcr.9.4.422","article-title":"Adipokines in relation to weight, lipid profile and glycemic state in women with polycystic ovary syndrome","volume":"9","author":"Al-Mayoofee SHB","year":"2024","unstructured":"Al-Mayoofee SHB, Missaoui N, Hmissa S, Al-Snafi AE. Adipokines in relation to weight, lipid profile and glycemic state in women with polycystic ovary syndrome. J Obstet Gynecol Res. 2024, 9:422-27. 10.30699\/jogcr.9.4.422","journal-title":"J Obstet Gynecol Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s43043-023-00158-2","article-title":"Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers","volume":"28","author":"Dey R","year":"2023","unstructured":"Dey R, Bhattacharya K, Basak AK, et al.. Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers. Middle East Fertil Soc J. 2023, 28:33. 10.1186\/s43043-023-00158-2","journal-title":"Middle East Fertil Soc J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361816-adipokine-dysregulation-in-obese-and-non-obese-polycystic-ovary-syndrome-pcos-patients-association-with-visceral-adiposity-index-and-metabolic-risk","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T05:52:48Z","timestamp":1752299568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361816-adipokine-dysregulation-in-obese-and-non-obese-polycystic-ovary-syndrome-pcos-patients-association-with-visceral-adiposity-index-and-metabolic-risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.87755","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}